Targeting ligand-functionalized and redox-sensitive heparin-Pluronic nanogels for intracellular protein delivery

Biomedical Materials

Volumn 6, Issue 5, 2011, Pages

  Nguyen, Dai Hai ^a   Joung, Yoon Ki ^a   Choi, Jong Hoon ^a   Moon, Hyun Tae ^b   Park, Ki Dong ^a  

^a Ajou University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COVALENT BONDS; CRITICAL MICELLE CONCENTRATION; FUNCTIONAL GROUPS; PEPTIDES; POLYSACCHARIDES;

AFM; AQUEOUS MEDIUM; CELLULAR UPTAKE; CYSTAMINE; DISULFIDE BONDS; GLUTATHIONES; HIGH REACTIVITY; HYDROXYL GROUPS; INTRACELLULAR PROTEIN DELIVERY; MEAN DIAMETER; MULTI-FUNCTIONAL; NANOCARRIERS; NANOGELS; PLURONICS; SPHERICAL SHAPE; THIOL GROUPS; TOLUIDINE BLUE; VINYL SULFONES;

NANOSTRUCTURED MATERIALS;

5,5' DITHIOBIS(2 NITROBENZOIC ACID); CELL PROTEIN; CYCLO(ARGINYLGLYCYLASPARTYL DEXTRO PHENYLALANYLCYSTEINE) PEPTIDE; CYSTAMINE; CYSTEINYLARGINYLGLUTAMYLLYSYLALANINE; GLUTATHIONE; HEPARIN; HEPARIN PLURONIC NANOGEL; HYDROXYL GROUP; NANOCARRIER; PEPTIDE DERIVATIVE; POLOXAMER; RIBONUCLEASE A; TOLUIDINE DERIVATIVE; UNCLASSIFIED DRUG; VINYL DERIVATIVE; BIOMATERIAL; CYCLOPEPTIDE; LIGAND; NANOCONJUGATE; OLIGOPEPTIDE; PANCREATIC RIBONUCLEASE;

ANIMAL CELL; ATOMIC FORCE MICROSCOPY; BINDING AFFINITY; CHEMICAL STRUCTURE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; DISULFIDE BOND; DRUG DELIVERY SYSTEM; ENCAPSULATION; INFRARED SPECTROSCOPY; LIGHT SCATTERING; MICELLE; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; ACTIVE TRANSPORT; ANIMAL; ARTICLE; CELL STRAIN 3T3; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; GEL; MATERIALS TESTING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION REACTION; PARTICLE SIZE; SYNTHESIS;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL TRANSPORT, ACTIVE; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; GELS; HEPARIN; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MATERIALS TESTING; MICE; NANOCONJUGATES; NIH 3T3 CELLS; OLIGOPEPTIDES; OXIDATION-REDUCTION; PARTICLE SIZE; PEPTIDES, CYCLIC; POLOXAMER; RIBONUCLEASE, PANCREATIC; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 80053549881     PISSN: 17486041     EISSN: 1748605X     Source Type: Journal    
DOI: 10.1088/1748-6041/6/5/055004     Document Type: Conference Paper

References (41)

1. Bae Y, Fukushima S, Harada A and Kataoka K 2003 Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change Angew. Chem. Int. Edn. 42 4640-3
2. Oh K T, Yin H Q, Lee E S and Bae Y H 2007 Polymeric nanovehicles for anticancer drugs with triggering release mechanisms J. Mater. Chem. 17 3987-4001 (Pubitemid 47482954)
3. Bajpai A K, Shukla S K, Bhanu S and Kankane S 2008 Responsive polymers in controlled drug delivery Prog. Polym. Sci. 33 1088-118
4. Ganta S, Devalapally H, Shahiwala A and Amiji M 2008 A review of stimuli-responsive nanocarriers for drug and gene delivery J. Control. Release 126 187-204
5. Meng F, Zhong Z and Feijen J 2009 Stimuli-responsive polymersomes for programmed drug delivery Biomacromolecules 10 197-209
6. Hruby M, Konak C and Ulbrich K 2005 Polymeric micellar pH-sensitive drug delivery system for doxorubicin J. Control. Release 103 137-48 (Pubitemid 40248568)
7. Meister A and Anderson M E 1983 Glutathione Annu. Rev. Biochem. 52 711-60 (Pubitemid 13030692)
8. Bae K H, Mok H and Park T G 2008 Synthesis, characterization, and intracellular delivery of reducible heparin nanogels for apoptotic cell death Biomaterials 29 3376-83
9. Bae J W, Lee E, Park K M and Park K D 2009 Vinyl sulfone-terminated PEG-PLLA diblock copolymer for thiol-reactive polymeric micelle Macromolecules 42 3437-42
10. Rehor A, Schmoekel H, Tirelli N and Hubbell J A 2008 Functionalization of polysulfide nanoparticles and their performance as circulating carriers Biomaterials 29 1958-66
11. Capila I and Linhardt R J 2002 Heparin-protein interactions Angew. Chem. Int. Edn 41 390-412
12. Choi J H, Jang J Y, Joung Y K, Kwon M H and Park K D 2010 Intracellular delivery and anti-cancer effect of self-assembled heparin-Pluronic nanogels with RNase A J. Control. Release 147 420-7
13. Moon H T, Jeon O C, Byun Y, Kim Y J and Lee Y K 2009 Evaluation of the oral absorption of heparin conjugated with sodium deoxycholate as a facilitating agent in GI tract Macromol. Res. 17 79-83
14. Zhoua H J, Qiana J C, Wang J, Yao W T, Liu C S, Chen J G and Cao X H 2009 Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo Biomaterials 30 1715-24
15. Niers T M, Klerk C P, DiNisio M, van Noorden C J, Buller H R, Reitsma P H and Richel D J 2007 Mechanisms of heparin induced anti-cancer activity in experimental cancer models Crit. Rev. Oncol. Hematol. 61 195-207 (Pubitemid 46329424)
16. Karti S S, Ovali E, Ozgur O, Yilmaz M, Sonmez M, Ratip S and Ozdemir F 2003 Induction of apoptosis and inhibition of growth of human hepatoma HepG2 cells by heparin Hepatogastroenterology 50 1864-6 (Pubitemid 37467949)
17. Li H L et al 2001 Effect of heparin on apoptosis in human nasopharyngeal carcinoma CNE2 cells Cell Res. 11 311-5 (Pubitemid 33677264)
18. Chen G and Hoffman A S 1995 Graft copolymers that exhibit temperature-induced phase transitions over a wide range of pH Nature 373 49-52
19. Park K M, Bae J W, Joung Y K, Shin J W and Park K D 2008 Nanoaggregate of thermosensitive chitosan-Pluronic for sustained release of hydrophobic drug Colloids Surf. B 63 1-6
20. Batrakova E V and Kabanov A V 2008 Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers J. Control. Release 130 98-106
21. Diego A C, Christian H, Carlos T and Alejandro S 2010 Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailaibility Nanomedicine 5 11-23
22. Ohtsuka N, Konno T, Miyauchi Y and Maeda H 1987 Anticancer effects of arterial administration of the anticancer agent SMANCS with lipiodol on metastatic lymph nodes Cancer 59 1560-5 (Pubitemid 17060095)
23. Duncan R 1999 Polymer conjugates for tumour targeting and intracytoplasmic delivery. The EPR effect as a common gateway? Pharm. Sci. Technol. Today 2 441-9 (Pubitemid 29528143)
24. Lee J I and Yoo H S 2008 Pluronic decorated-nanogels with temperature-responsive volume transitions, cytotoxicities, and transfection efficiencies Eur. J. Pharm. Biopharm. 70 506-13
25. Dijkgraaf I, Kruijtzer J A W, Liu S, Soede A C, Oyen W J G, Corstens F H M, Liskamp R M J and Boerman O C 2007 Improved targeting of the αvβ3 integrin by multimerization of RGD peptides Eur. J. Nucl. Med. Mol. Imaging 34 267-73 (Pubitemid 46147510)
26. Atmaja B, Lui B H, Hu Y, Beck S E, Frank C W and Cochran J R 2010 Targeting of cancer cells using quantum dot-polypeptide hybrid assemblies that function as molecular imaging agents and carrier systems Adv. Funct. Mater. 20 4091-7
27. Allen C, Maysinger D and Eisenberg A 1999 Nano-engineering block copolymer aggregates for drug delivery Colloids Surf. B 16 3-27
28. Matousek J, Pouckova P, Hlouskova D, Zadinova M, Soucek J and Skvor J 2004 Effect of hyaluronidase and PEG chain conjugation on the biologic and antitumor activity of RNase A J. Control. Release 94 401-10 (Pubitemid 38117150)
29. Smith P K, Mallia A K and Hermanson G T 1980 Toluidine blue Anal. Biochem. 109 466-73
30. Ellman G L 1959 Tissue sulfhydryl groups Arch. Biochem. Biophys. 82 70-7
31. Ahmed H 2005 Principles and Reactions of Protein Extraction, Purification, and Characterization (Boca Raton, FL: CRC Press) pp 49-60
32. Lee H Y, Yu S A, Jeong K H and Kim Y J 2007 Poly(vinyl pyrrolidone) conjugated lipid system for the hydrophobic drug delivery Macromol. Res. 15 547-52
33. Kabanov A V, Nazarova I R, Astafieva I V, Batrakova E V, Alakhov V Y, Yaroslavov A A and Kabanov V A 1995 Micelle formation and solubilization of fluorescent probes in poly(oxyethylene-b-oxypropylene-b-oxyethylene) solutions Macromolecules 28 2303-14
34. Kozlov M Y, Melik N S, Batrakova E V and Kabanov A V 2000 Relationship between pluronic block copolymer structure, critical micellization concentration and partitioning coefficients of low molecular mass solutes Macromolecules 33 3305-13
35. Jain R K 1998 Delivery of molecular and cellular medicine to solid tumors J Control. Release 53 49-67 (Pubitemid 28218689)
36. Griffiths G, Back R and Marsh M 1989 A quantitative analysis of the endocytic pathway in baby hamster kidney cells J. Cell Biol. 109 2703-20 (Pubitemid 20011898)
37. Santos J R, Alves N M and Mano J F 2010 New thermo-responsive hydrogels based on poly (N-isopropylacrylamide)/hyaluronic acid semi-interpenetrated polymer networks: swelling properties and drug release studies J. Bioact. Compat. Polym. 25 169-84
38. Choi S H, Lee J H, Choi S M and Park T G 2006 Thermally reversible pluronic/heparin nanocapsules exhibiting 1000-fold volume transition Langmuir 22 1758-62
39. Rosenberg H F 2008 RNase A ribonucleases and host defense: an evolving story J. Leukoc. Biol. 83 1079-87 (Pubitemid 351960339)
40. Klink T A and Raines R T 2000 Conformational stability is a determinant of ribonuclease a cytotoxicity J. Biol. Chem. 275 17463-7 (Pubitemid 30430785)
41. Naddeo M, Vitagliano L, Russo A, Gotte G, D'Alessio G and Sorrentino S 2005 Interactions of the cytotoxic RNase A dimers with the cytosolic ribonuclease inhibitor FEBS Lett. 579 2663-8 (Pubitemid 40615674)